NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 57 filers reported holding ORAMED PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4,111
-27.1%
1,5750.0%0.00%
Q2 2023$5,639
+64.2%
1,5750.0%0.00%
Q1 2023$3,434
-81.9%
1,5750.0%0.00%
Q4 2022$18,947
+89.5%
1,5750.0%0.00%
Q3 2022$10,000
-9.1%
1,575
-5.5%
0.00%
Q1 2015$11,0001,667
+3869.0%
0.00%
Q1 2014$0420.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 576,317$1,504,0001.50%
Phoenix Holdings Ltd. 197,763$483,0000.02%
Frontier Wealth Management LLC 71,900$188,0000.02%
GSA CAPITAL PARTNERS LLP 19,659$51,0000.01%
Rossmore Private Capital 15,061$39,0000.01%
ETF MANAGERS GROUP, LLC 98,486$255,0000.01%
Virtu Financial LLC 10,450$27,0000.01%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$15,0000.01%
Sterling Investment Advisors, Ltd. 3,150$8,0000.00%
Qube Research & Technologies Ltd 75,395$197,0000.00%
View complete list of ORAMED PHARMACEUTICALS INC shareholders